Andrew is a world renowned expert for clinical translation in oncology leading 10 novel antibodies/recombinant proteins successfully through preclinical development, humanization, production/regulatory compliance, and first-in-human and Phase I/II trials in cancer patients. He has published more than 240 peer-reviewed papers and 20 book chapters, principally in oncology and molecular imaging, Currently Director of the PET Centre at Austin Health, Program leader in the ONJ Cancer Institute, Chairman of the Australian and New Zealand Society of Nuclear Medicine and is President of the World Federation of Nuclear Medicine and Biology
Miles is an internationally recognised haematologist who has led many CD30 lymphoma clinical trials, including the applications of Adcetris as a new-line ADC biotherapeutic drug. He is the Director of Molecular Oncology and Cancer Immunology at Epworth Healthcare and Director of the Centre for Blood Cell Therapy at Peter MacCallum Cancer Centre. He holds faculty Professorships at both Melbourne and Monash Universities and is also a Director at the Snowdome Foundation; the International Society of Cutaneous Lymphoma; and the Myeloma Foundation Australia; Professor Prince holds major Australian, American and European research grants and has published over 370 journal articles. He is a member of the Australian, America and European Societies of Haematology. His work has been recognised with an Order of Australia.
As Director of Radiology, Rod has pioneered the use of PET in the assessment of cancer and has managed over 60,000 PET studies performed in the PET Center he founded in 1996. He has introduced a number of novel imaging techniques that provide enhanced diagnosis and evaluation of cancer behaviour. He is a specialist in RIT therapy and holds numerous national and international research grants. Rod is on 8 editorial boards, has published over 300 peer-reviewed articles and more than 15 book chapters.